Regulations.gov document
Reference 3 - Background Material for NAD1 Blood Products Advisory Committee Meeting…
Supporting & Related Material · FDA-2005-D-0208 · posted Jul 18, 2008
Key facts
| Document ID | FDA-2005-D-0208-0013 |
|---|---|
| Title | Reference 3 - Background Material for NAD1 Blood Products Advisory Committee Meeting, March 2000[FDA-2005-D-0208-0002] - Transcript |
| Document type | Supporting & Related Material |
| Subtype | BKG-Background Material |
| Agency | FDA |
| Docket | FDA-2005-D-0208 |
| Posted | Jul 18, 2008 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: